Lichen Planus Myths Debunked: Separating Fact from Fiction
Table of Contents
Estimated reading time: 12 minutes
Lichen Planus (LP) is a chronic inflammatory condition affecting the skin, mucous membranes, nails, and hair. While it may not be life-threatening, it can lead to persistent symptoms, including itching, pain, and discomfort, affecting the quality of life (Robinson et al., 2020). Despite advancements in medical understanding, misconceptions about LP persist. In this article, we debunk some of the most common myths surrounding Lichen Planus, bringing clarity through both modern insights and Ayurvedic perspectives (Mishra et al., 2020).
Lichen Planus Myths
Myth 1: Lichen Planus Is Contagious
Fact: One of the most common misconceptions about Lichen Planus is that it is contagious. LP is not contagious. It is an autoimmune disorder where the immune system attacks healthy tissue, leading to inflammation. You cannot contract LP from someone else, nor can you spread it through physical contact or shared personal items (Seo & Lim, 2021). This understanding helps alleviate unnecessary stigma or fear associated with this condition.
Myth 2: Poor Hygiene Causes Lichen Planus
Fact: Lichen Planus is not caused by poor hygiene. This myth often stems from the visible nature of the condition, which can cause red, irritated lesions or plaques on the skin. In reality, LP is the result of immune system dysregulation, not inadequate skin care (Kumar & Gupta, 2019). Maintaining proper hygiene can support overall skin health, but it does not influence the development of Lichen Planus (Mishra et al., 2020).
Myth 3: Lichen Planus Only Affects the Skin
Fact: While LP commonly affects the skin, it can manifest in various parts of the body, including the mucous membranes (mouth, genital areas), nails, and scalp. Oral Lichen Planus, for example, causes painful white patches or sores inside the mouth, while Lichen Planopilaris affects the scalp, leading to hair loss (Shah & Clark, 2020). Recognizing LP as more than just a skin condition is crucial for comprehensive diagnosis and management (Robinson et al., 2020).
Myth 4: There Is a Cure for Lichen Planus
Fact: Unfortunately, there is no cure for Lichen Planus. It is a chronic condition, meaning it may last for years, with periods of remission and flare-ups. However, proper management and treatment can help control symptoms, reduce flare-ups, and improve quality of life (Seo & Lim, 2021). Both conventional and Ayurvedic treatments focus on long-term management rather than offering a cure (Mishra et al., 2020).
Myth 5: Stress Does Not Affect Lichen Planus
Fact: Stress plays a significant role in triggering and exacerbating autoimmune conditions like Lichen Planus. Stress affects the immune system, leading to increased inflammation and, in some cases, triggering flare-ups of LP (Robinson et al., 2020). Ayurvedic treatment places great emphasis on stress management as a key component of healing, recognizing the mind-body connection. Techniques such as yoga, meditation, and breathing exercises help in reducing stress and maintaining balance (Sharma & Chandola, 2011).
Myth 6: Lichen Planus Will Go Away On Its Own
Fact: While Lichen Planus can sometimes go into remission without treatment, many cases persist or recur without intervention. Some individuals may experience spontaneous remission, but others may have ongoing or recurring symptoms that require long-term management (Shah & Clark, 2020). Ayurveda recommends a proactive approach with personalized strategies to manage doshic imbalances and prevent flare-ups (Mishra et al., 2020).
Myth 7: Diet Has No Effect on Lichen Planus
Fact: Ayurveda views diet as a fundamental element in managing inflammation and overall health. Dietary modifications can play a significant role in reducing the symptoms of Lichen Planus (Sharma & Chandola, 2011). Cooling, anti-inflammatory foods are recommended, particularly those that pacify the Pitta dosha, which governs inflammation. Spicy, acidic, and processed foods that exacerbate inflammation and the buildup of toxins (Ama) should be avoided (Lad, 2012). In both conventional and Ayurvedic systems, diet supports the body’s natural healing processes (Mishra et al., 2020).
Myth 8: All Treatments Work the Same for Everyone
Fact: Treatment for Lichen Planus is not one-size-fits-all. The condition varies significantly from person to person, and so does the effectiveness of treatments. While conventional medicine offers treatments such as corticosteroids and immunosuppressants, Ayurveda focuses on understanding the unique Prakriti (constitution) and Vikruti (imbalance) of each individual (Jaiswal & Williams, 2017). A personalized approach is necessary for long-term management and prevention of future flare-ups, balancing the body’s doshas to promote harmony (Sharma & Chandola, 2011).
Myth 9: Sun Exposure Helps to Clear Lichen Planus Lesions
Fact: While some skin conditions benefit from controlled UV exposure, this is not universally applicable to Lichen Planus. In fact, excessive sun exposure can worsen LP in certain individuals, particularly those with oral or genital LP. The lesions might become more irritated, and prolonged sun exposure increases the risk of skin damage (Robinson et al., 2020). Both Ayurvedic and conventional practices recommend protecting the skin and avoiding excessive sun exposure, which can lead to further complications (Sharma & Chandola, 2011).
Fact: Not all cases of Lichen Planus require aggressive treatment. Mild cases may benefit from gentle management through lifestyle changes, stress reduction, and proper skin care (Shah & Clark, 2020). Ayurveda emphasizes long-term healing through balancing the body’s energies rather than opting for aggressive short-term fixes (Mishra et al., 2020). This approach minimizes side effects and focuses on maintaining balance and health rather than only symptom suppression (Jaiswal & Williams, 2017).
Conclusion: Understanding Lichen Planus for Better Management
Understanding the facts about Lichen Planus is essential for effective management. While the condition can be chronic and recurrent, a holistic approach that integrates Ayurvedic principles and personalized care can make a significant difference in long-term health (Sharma & Chandola, 2011). Ayurvedic treatment emphasizes balancing the body’s doshas, detoxifying from within, and addressing both the physical and emotional aspects of the disease. By debunking common myths and focusing on a comprehensive understanding of LP, individuals can take control of their health, manage symptoms more effectively, and improve their overall quality of life (Mishra et al., 2020).
1. Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012; 366: 723–732. [PubMed] [Google Scholar]
2. Browning J. Dermatology, Edited by Bolognia Jean L., Schaffer Julie V., Cerroni Lorenzo Fourth edition; China: Elsevier, 2018, ISBN 978–0-7020–6275–9. Pediatric Dermatology 2018; 35: 289. [Google Scholar]
3. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, et al.. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis 2021; 27: 813–828. [PubMed] [Google Scholar]
4. Sawant NS, Vanjari NA, Khopkar U, Adulkar S. A study of depression and quality of life in patients of lichen planus. Scientific World Journal 2015; 2015: 817481. [PMC free article] [PubMed] [Google Scholar]
5. Mansur AT, Kilic Z, Atalay F. Psychological evaluation of patients with cutaneous lichen planus. Dermatol Psychosomat 2004; 5: 132–136. [Google Scholar]
6. Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, et al.. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984–991. [PMC free article] [PubMed] [Google Scholar]
7. López-Jornet P, Camacho-Alonso F. Quality of life in patients with oral lichen planus. J Eval Clin Pract 2010; 16: 111–113. [PubMed] [Google Scholar]
8. Cheng H, Oakley A, Conaglen JV, Conaglen HM. Quality of life and sexual distress in women with erosive vulvovaginal lichen planus. J Low Genit Tract Dis 2017; 21: 145–149. [PubMed] [Google Scholar]
9. Radwan-Oczko M, Zwyrtek E, Owczarek JE, Szcześniak D. Psychopathological profile and quality of life of patients with oral lichen planus. J Appl Oral Sci 2018; 26: e20170146. [PMC free article] [PubMed] [Google Scholar]
10. Rojo-Moreno J, Bagán J, Rojo-Moreno J, Donat JS, Milián MA, Jiménez Y. Psychologic factors and oral lichen planus: a psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 687–691. [PubMed] [Google Scholar]
11. Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009; 121: 154–161. [PubMed] [Google Scholar]
12. Jafferany M, Patel A. Understanding psychocutaneous disease: psychosocial & psychoneuroimmunologic perspectives. Int J Dermatol 2020; 59: 8–15. [PubMed] [Google Scholar]
13. Ghosh S, Behere RV, Sharma P, Sreejayan K. Psychiatric evaluation in dermatology: an overview. Indian J Dermatol 2013; 58: 39–43. [PMC free article] [PubMed] [Google Scholar]
14. Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol 2008; 22: 1435–1444. [PubMed] [Google Scholar]
15. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216. [PubMed] [Google Scholar]
17. Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 2011; 63: S454–S566. [PubMed] [Google Scholar]
18. Eckstein PP. Angewandte Statistik mit SPSS: Praktische Einführung für Wirtschaftswissenschaftler. Springer Medizin Verlag, Heidelberg, 2006. [Google Scholar]
19. Field, Andy. 2013. Discovering Statistics Using IBM SPSS Statistics. 4th ed. London, England: SAGE Publications. [Google Scholar]
20. Eckey H-F, Türck M. Statistische Signifikanz (p-Wert). WiStWirtschaftswissenschaftliches Studium 2006; 35: 415–418. [Google Scholar]
21. Lehmann EL. Consistency and unbiasedness of certain nonparametric tests. Ann Math Statist 1951; 22: 165–179. [Google Scholar]
23. Fahrmeir L, Heumann C, Künstler R, Pigeot I, Tutz G. Statistik: Der weg zur datenanalyse. Springer-Verlag Berlin, Heidelberg, 2016. . [Google Scholar]
24. Bortz J, Lienert GA. Kurzgefasste Statistik für die klinische Forschung: Leitfaden für die verteilungsfreie Analyse kleiner Stichproben. Springer Medizin Verlag, Heidelberg, 2008. [Google Scholar]
25. Bender R, Lange S. Was ist der p-Wert? Deutsche Medizinische Wochenschrift 2001; 126: T39–T40. [PubMed] [Google Scholar]
26. Bland JM, Bland D. Statistics notes: one and two sided tests of significance. BMJ 1994; 309: 248. [PMC free article] [PubMed] [Google Scholar]
28. Picardi A, Amerio P, Baliva G, Barbieri C, Teofoli P, Bolli S, et al.. Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 2004; 84: 213–217. [PubMed] [Google Scholar]
29. Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70: 118–136. [PubMed] [Google Scholar]
30. Allen CM, Beck FM, Rossie KM, Kaul TJ. Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986; 61: 44–46. [PubMed] [Google Scholar]
31. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008; 21: 54–59. [PubMed] [Google Scholar]
32. Boehm D, Schmid-Ott G, Finkeldey F, John SM, Dwinger C, Werfel T, et al.. Anxiety, depression and impaired healthrelated quality of life in patients with occupational hand eczema. Contact Dermatitis 2012; 67: 184–192. [PubMed] [Google Scholar]
33. Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol 2014; 134: 1542–1551. [PubMed] [Google Scholar]
34. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401–407. [PubMed] [Google Scholar]
35. Feldman SR. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 2020; 82: 256–257. [PubMed] [Google Scholar]
36. Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners’ guidelines. Clin Cosmet Investig Dermatol 2017; 10: 117–132. [PMC free article] [PubMed] [Google Scholar]
37. Finlay AY, Salek MS, Abeni D, Tomás-Aragonés L, van Cranenburgh OD, Evers AW, et al.. Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on Quality of Life. J Eur Acad Dermatol Venereol 2017; 31: 424–431. [PubMed] [Google Scholar]
38. Richards HL, Fortune DG, Weidmann A, Sweeney SKT, Griffiths CEM. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 2004; 151: 1227–1233. [PubMed] [Google Scholar]
39. Donnarumma M, Fattore D, Greco V, Ferrillo M, Vastarella M, Chiodini P, et al.. How to increase adherence and compliance in acne treatment? A combined strategy of SMS and visual instruction leaflet. Dermatology 2019; 235: 463–470. [PubMed] [Google Scholar]
40. Marasca C, Napolitano M, Monfrecola G, Masarà A, Annunziata MC, Donnarumma M, et al.. Quality of life in people living with patients suffering from hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020; 34: e342–34e3. [PubMed] [Google Scholar]
41. Osman OT, Mufaddel A, Almugaddam F, Augusterfer EF. The psychiatric aspects of skin disorders. Exp Rev Dermatol 2011; 6: 195–209. [Google Scholar]
